US HB2339 | 2019-2020 | 116th Congress

Status

Spectrum: Partisan Bill (Democrat 125-2)
Status: Engrossed on March 2 2020 - 50% progression
Action: 2020-03-02 - Received in the Senate and Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Engrossed) [PDF]

Summary

Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020 This bill revises requirements related to the safety, sale, and advertisement of tobacco products, including electronic nicotine delivery systems (e.g., e-cigarettes, e-hookah, e-cigars, and vape pens). Among other requirements, the bill requires the Food and Drug Administration (FDA) to implement regulations to require color graphics on the labeling of cigarette packages, depicting the negative health consequences of smoking; requires the FDA to apply regulations on tobacco products to all tobacco products, including e-cigarettes; generally prohibits the retail online sale of tobacco products, including electronic nicotine delivery systems; prohibits flavors other than tobacco in a tobacco product; prohibits the use of flavored products in an electronic nicotine delivery system, except in specified circumstances; increases the user fees that the FDA collects from manufacturers and importers; directs the FDA to regulate products containing nicotine not made or derived from tobacco plants (including nicotine from chemical synthesis, recombinant genetic technology, or extraction from non-tobacco plants); imposes an excise tax on nicotine that has been extracted, concentrated, or synthesized; provides funding through FY2025 to support public education regarding tobacco regulation, public awareness regarding the harms associated with tobacco use, outreach to medically underserved communities regarding tobacco-use prevention and cessation, research grants related to tobacco-use prevention and cessation, and grants to health centers for tobacco-use cessation treatment; establishes and provides funding through FY2025 for a demonstration grant program to develop strategies for smoking cessation (including of the use of menthol-flavored tobacco products) in medically underserved communities; beginning in 2024, waives coinsurance under Medicare for colorectal-cancer screening tests; specifies that a health insurance plan may still be treated, for certain tax-deduction purposes, as a high-deductible plan even if it does not have a deductible for certain inhalers or nebulizers; exempts certain cigars from premarket review requirements; increases civil penalties for certain violations of restrictions on the sale of tobacco products; and requires the Government Accountability Office to study e-cigarettes.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020

Sponsors

Rep. Frank Pallone [D-NJ]Rep. Donna Shalala [D-FL]Rep. Bobby Rush [D-IL]Rep. Barbara Lee [D-CA]
Rep. John Sarbanes [D-MD]Rep. Lauren Underwood [D-IL]Rep. Lisa Rochester [D-DE]Rep. Debbie Mucarsel-Powell [D-FL]
Rep. Janice Schakowsky [D-IL]Rep. Joseph Neguse [D-CO]Rep. Mike Quigley [D-IL]Rep. Thomas Suozzi [D-NY]
Rep. Tim Ryan [D-OH]Rep. Jamie Raskin [D-MD]Rep. Paul Tonko [D-NY]Rep. Steve Cohen [D-TN]
Rep. Eliot Engel [D-NY]Rep. Terri Sewell [D-AL]Rep. Joseph Kennedy [D-MA]Rep. Chellie Pingree [D-ME]
Rep. Debbie Wasserman Schultz [D-FL]Rep. Rick Larsen [D-WA]Rep. Elijah Cummings [D-MD]Rep. Eleanor Norton [D-DC]
Rep. Ted Lieu [D-CA]Rep. Angela Craig [D-MN]Rep. Peter King [R-NY]Rep. Nita Lowey [D-NY]
Rep. John Lewis [D-GA]Rep. Betty McCollum [D-MN]Rep. Bonnie Coleman [D-NJ]Rep. Katie Hill [D-CA]
Rep. TJ Cox [D-CA]Rep. Rashida Tlaib [D-MI]Rep. Kim Schrier [D-WA]Rep. Alcee Hastings [D-FL]
Rep. Ann Kirkpatrick [D-AZ]Rep. Lucille Roybal-Allard [D-CA]Rep. Derek Kilmer [D-WA]Rep. Haley Stevens [D-MI]
Rep. Debbie Dingell [D-MI]Rep. Ann Kuster [D-NH]Rep. Bennie Thompson [D-MS]Rep. Christopher Pappas [D-NH]
Rep. Theodore Deutch [D-FL]Rep. Julia Brownley [D-CA]Rep. Bill Foster [D-IL]Rep. Denny Heck [D-WA]
Rep. Harley Rouda [D-CA]Rep. Grace Napolitano [D-CA]Rep. Raja Krishnamoorthi [D-IL]Rep. Mark Pocan [D-WI]
Rep. Danny Davis [D-IL]Rep. Mike Levin [D-CA]Rep. Gil Cisneros [D-CA]Rep. Susan Davis [D-CA]
Rep. Grace Meng [D-NY]Rep. Josh Gottheimer [D-NJ]Rep. Al Lawson [D-FL]Rep. Eddie Johnson [D-TX]
Rep. Ayanna Pressley [D-MA]Rep. Nanette Barragan [D-CA]Rep. Stacey Plaskett [D-VI]Rep. Matthew Cartwright [D-PA]
Rep. Robin Kelly [D-IL]Rep. Max Rose [D-NY]Rep. Andy Kim [D-NJ]Rep. Donald Payne [D-NJ]
Rep. Ed Case [D-HI]Rep. Jahana Hayes [D-CT]Rep. Donald Norcross [D-NJ]Rep. James Langevin [D-RI]
Rep. Doris Matsui [D-CA]Rep. Raul Ruiz [D-CA]Rep. Jared Huffman [D-CA]Rep. Val Demings [D-FL]
Rep. Daniel Kildee [D-MI]Rep. Chrissy Houlahan [D-PA]Rep. Mark DeSaulnier [D-CA]Rep. Ami Bera [D-CA]
Rep. Brenda Lawrence [D-MI]Rep. Mark Takano [D-CA]Rep. Ro Khanna [D-CA]Rep. Jerry McNerney [D-CA]
Rep. Ben Lujan [D-NM]Rep. Jesus Garcia [D-IL]Rep. Darren Soto [D-FL]Rep. Earl Blumenauer [D-OR]
Rep. Judy Chu [D-CA]Rep. Madeleine Dean [D-PA]Rep. Gwen Moore [D-WI]Rep. Zoe Lofgren [D-CA]
Rep. Mary Gay Scanlon [D-PA]Rep. Raul Grijalva [D-AZ]Rep. David Trone [D-MD]Rep. Katie Porter [D-CA]
Rep. Tom Malinowski [D-NJ]Rep. Sean Casten [D-IL]Rep. Linda Sanchez [D-CA]Rep. Dwight Evans [D-PA]
Rep. Joaquin Castro [D-TX]Rep. Eric Swalwell [D-CA]Rep. Joyce Beatty [D-OH]Rep. Jackie Speier [D-CA]
Rep. Suzanne Bonamici [D-OR]Rep. Adriano Espaillat [D-NY]Rep. Jose Serrano [D-NY]Rep. Elissa Slotkin [D-MI]
Rep. Sean Maloney [D-NY]Rep. Hakeem Jeffries [D-NY]Rep. Lucy McBath [D-GA]Rep. Kathleen Rice [D-NY]
Rep. Jerrold Nadler [D-NY]Rep. Sylvia Garcia [D-TX]Rep. Andre Carson [D-IN]Rep. Maxine Waters [D-CA]
Rep. Jimmy Gomez [D-CA]Rep. Debra Haaland [D-NM]Rep. Mike Thompson [D-CA]Rep. John Larson [D-CT]
Rep. Juan Vargas [D-CA]Rep. David Cicilline [D-RI]Rep. Brian Fitzpatrick [R-PA]Rep. Lacy Clay [D-MO]
Rep. Andy Levin [D-MI]Rep. Sheila Jackson-Lee [D-TX]Rep. Dean Phillips [D-MN]

Roll Calls

2020-02-28 - House - On passage RC# 78 (Y: 213 N: 195 NV: 0 Abs: 22) [PASS]
2020-02-28 - House - On motion to recommit with instructions RC# 77 (Y: 187 N: 220 NV: 0 Abs: 22) [FAIL]

History

DateChamberAction
2020-03-02SenateReceived in the Senate and Read twice and referred to the Committee on Finance.
2020-02-28HouseMotion to reconsider laid on the table Agreed to without objection.
2020-02-28HouseOn passage Passed by the Yeas and Nays: 213 - 195 (Roll no. 78). (text: CR H1257-1262)
2020-02-28HouseOn motion to recommit with instructions Failed by the Yeas and Nays: 187 - 220 (Roll no. 77).
2020-02-28HouseThe previous question on the motion to recommit with instructions was ordered without objection.
2020-02-28HouseFloor summary: DEBATE - The House proceeded with 10 minutes of debate on the Walden motion to recommit with instructions. The instructions contained in the motion seek to require the bill to be reported back to the House with an amendment to insert a new title at the end of the bill, "Born-Alive Abortion Survivors Protection."
2020-02-28HouseMr. Walden moved to recommit with instructions to the Committee on Energy and Commerce. (text: CR H1286-1287)
2020-02-28HouseConsidered as unfinished business. (consideration: CR H1286-1289)
2020-02-28HousePOSTPONED PROCEEDINGS - Pursuant to clause 1(c) of Rule XIX, further proceedings on H.R. 2339 were postponed.
2020-02-28HouseThe previous question was ordered pursuant to the rule.
2020-02-28HouseDEBATE - The House proceeded with 90 minutes of debate on H.R. 2339.
2020-02-28HouseRule provides for consideration of H.R. 2339 with 1 hour and 30 minutes of general debate. Motion to recommit with or without instructions allowed.
2020-02-28HouseConsidered under the provisions of rule H. Res. 866. (consideration: CR H1257-1286)
2020-02-27HouseRule H. Res. 866 passed House.
2020-02-26HouseRules Committee Resolution H. Res. 866 Reported to House. Rule provides for consideration of H.R. 2339 with 1 hour and 30 minutes of general debate. Motion to recommit with or without instructions allowed.
2020-02-21HousePlaced on the Union Calendar, Calendar No. 324.
2020-02-21HouseReported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-402.
2019-11-19HouseOrdered to be Reported (Amended) by the Yeas and Nays: 28 - 24.
2019-11-19HouseCommittee Consideration and Mark-up Session Held.
2019-11-13HouseForwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
2019-11-13HouseSubcommittee Consideration and Mark-up Session Held.
2019-10-16HouseSubcommittee Hearings Held.
2019-04-19HouseReferred to the Subcommittee on Health.
2019-04-18HouseReferred to the House Committee on Energy and Commerce.
2019-04-18HouseIntroduced in House

Same As/Similar To

SB3174 (Related) 2020-01-09 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
HR866 (Related) 2020-02-27 - Motion to reconsider laid on the table Agreed to without objection.
HB1570 (Related) 2019-03-08 - Sponsor introductory remarks on measure. (CR H2608)
HB4716 (Related) 2020-02-21 - Placed on the Union Calendar, Calendar No. 323.
HB4742 (Related) 2020-02-21 - Placed on the Union Calendar, Calendar No. 322.

Subjects

Administrative law and regulatory procedures
Cancer
Cardiovascular and respiratory health
Child health
Civil actions and liability
Congressional oversight
Consumer affairs
Department of Health and Human Services
Digestive and metabolic diseases
Drug safety, medical device, and laboratory regulation
Drug, alcohol, tobacco use
Food and Drug Administration (FDA)
Government information and archives
Government studies and investigations
Health
Health care costs and insurance
Health care coverage and access
Health facilities and institutions
Health information and medical records
Health programs administration and funding
Health promotion and preventive care
Health technology, devices, supplies
Marketing and advertising
Medical research
Medical tests and diagnostic methods
Medicare
Mental health
Minority health
Racial and ethnic relations
Research administration and funding
Retail and wholesale trades
Sales and excise taxes
State and local courts
State and local government operations
User charges and fees

US Congress State Sources


Bill Comments

feedback